Innolux’s intelligent chemotherapy compounding robotic arm with 4 major advantages to provide a smart medical solution

Miaoli, Dec. 2, 2023- Chi Mei Medical Center collaborates with Innolux to develop the first domestically researched and manufactured intelligent chemotherapy compounding robotic arm in Taiwan.  It also marks the first hospital in southern Taiwan to utilize this intelligent chemotherapy compounding robotic arm for hazardous drug compounding operations.  The intelligent chemotherapy compounding robotic arm represents a significant innovation in the medical industry, boasting four major advantages: safety, precision, traceability, and efficiency improvement. This innovative technology not only enhances the accuracy of medication compounding but also ensures the safety of pharmacists and patients, further providing a smart medical solution for shortage of pharmacists and excessive workload.

The intelligent chemotherapy compounding robotic arm can compound genetically hazardous anticancer drugs in a sterile environment, meeting the cleanliness requirements of aseptic drug compounding settings.  Besides protecting patients from microbial contamination, it also shields pharmacists from exposure to hazardous drug environments, adhering to occupational health and safety standards. The intelligent chemotherapy compounding robotic arm utilizes advanced recognition systems and information integration to ensure the accuracy and consistency of each medication, further ensuring patient medication safety.

The hardware components of the intelligent chemotherapy compounding robotic arm utilize nine modules for precise compounding of drugs, syringes, soft bags storage, drug identification, drug extraction, liquid mixing, weight confirmation, and more.  The software technology integrates hospital prescriptions, synchronizes compounding information sources, flexibly schedules compounding sequences, monitors compounding statuses in real-time, and automatically records the compounding process, achieving intelligent compounding.  Through compounding big data, it offers prescription decision support, optimizes drug management.

The intelligent chemotherapy compounding robotic arm represents a significant innovation in the medical industry, boasting four major advantages: safety, precision, traceability, and efficiency improvement, expected to positively impact the global healthcare system.  In the future, partnering with top-tier medical institutions in Taiwan to establish an international-standard chemotherapy drug compounding center.  It employs centralized automated manufacturing and a cold chain distribution system to serve regional healthcare institutions.

Contact: Corporate Communications, Innolux
Anita Chien  +886-(0)6-505-1888 #47153,+886-(0)911-572-225, [email protected]
Iris Tsou  +886-(0)37-586-000 #62329, [email protected]